Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes.

Moreover, when we stratified the eGFR during the baseline period into predefined classes (< 45; ≥ 45 and < 60; ≥ 60 and < 90; and ≥ 90), we noticed that the classes over 60 had a decreasing trend, and the class for the range from 45 and < 60 had an increasing trend in all the treatment groups.

also in 47,180 other papers